| scholarly article | Q13442814 |
| P2093 | author name string | Jun Zhang | |
| Yi Lu | |||
| Andrew Lu | |||
| Binghua Jiang | |||
| Derrick Beech | |||
| P2860 | cites work | Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 | Q24316075 |
| Tumor angiogenesis: therapeutic implications | Q27860595 | ||
| Deletion of p16 and p15 genes in brain tumors | Q28242452 | ||
| Hydroxylation of HIF-1: oxygen sensing at the molecular level | Q28276549 | ||
| Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma | Q28300339 | ||
| Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis | Q29547178 | ||
| Cancer statistics, 2007 | Q29547293 | ||
| The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. | Q33301664 | ||
| Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells | Q34047111 | ||
| Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma | Q34570747 | ||
| Manipulation of adenovirus vectors | Q34627721 | ||
| Development of adenovirus vectors for the expression of heterologous genes | Q39585186 | ||
| Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer. | Q40136580 | ||
| Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers | Q40245632 | ||
| Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models. | Q40745321 | ||
| RB2/p130 gene-enhanced expression down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo | Q40824459 | ||
| p16INK4A as a human tumor suppressor | Q40971258 | ||
| Angiogenesis: A Marker for Neoplastic Transformation of Mammary Papillary Hyperplasia | Q41232729 | ||
| Angiogenic growth factors in preinvasive breast disease. | Q41698525 | ||
| HaloTag: a novel protein labeling technology for cell imaging and protein analysis | Q42809086 | ||
| Demethylation by 5-aza-2'-deoxycytidine (5-azadC) of p16INK4A gene results in downregulation of vascular endothelial growth factor expression in human lung cancer cell lines | Q43758356 | ||
| TNF-related activation-induced cytokine (TRANCE) induces angiogenesis through the activation of Src and phospholipase C (PLC) in human endothelial cells | Q43821708 | ||
| Delivery of adenoviral vectors to the prostate for gene therapy | Q45856917 | ||
| In vivo expression of prostate-specific adenoviral vectors in a canine model | Q45862635 | ||
| Adenoviral vector containing wild-type p16 suppresses prostate cancer growth and prolongs survival by inducing cell senescence | Q45866767 | ||
| Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer | Q45887756 | ||
| Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells | Q46826131 | ||
| Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas. | Q48136880 | ||
| Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia | Q49298452 | ||
| Association of p53, p16, and vascular endothelial growth factor protein expressions with the prognosis and metastasis of gallbladder cancer | Q50177638 | ||
| Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer. | Q53448930 | ||
| Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms. | Q54790226 | ||
| Epidemiology. Search for a killer: focus shifts from fat to hormones | Q70554011 | ||
| Frequency of homozygous deletion at p16/CDKN2 in primary human tumours | Q71721193 | ||
| Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma | Q71862654 | ||
| Inhibition of colon tumor progression and angiogenesis by the Ink4a/Arf locus | Q73013865 | ||
| Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases | Q79336638 | ||
| Hypoxia-inducible factor-1alpha is associated with risk of aggressive behavior and tumor angiogenesis in gastrointestinal stromal tumor | Q81675946 | ||
| P921 | main subject | cancer metastasis | Q120912394 |
| tumor angiogenesis | Q110495869 | ||
| P304 | page(s) | 273-286 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Cancer therapy | Q27721028 |
| P1476 | title | Suppression of breast cancer metastasis through the inhibition of VEGF-mediated tumor angiogenesis | |
| P478 | volume | 5 |
| Q89522953 | Combretastatin A-4 disodium phosphate and low dose gamma irradiation suppress hepatocellular carcinoma by downregulating ROCK1 and VEGF gene expression |
| Q33634969 | Development of a Novel Anti-HIF-1α Screening System Coupled with Biochemical and Biological Validation for Rapidly Selecting Potent Anti-Cancer Compounds |
| Q39584487 | EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice |
| Q39468057 | Effects of Hypoxia, Surrounding Fibroblasts, and p16 Expression on Breast Cancer Cell Migration and Invasion |
| Q37631817 | Evidence for G-quadruplex in the promoter of vegfr-2 and its targeting to inhibit tumor angiogenesis |
| Q87466299 | Fenofibrate enhances radiosensitivity of esophageal squamous cell carcinoma by suppressing hypoxia-inducible factor-1α expression |
| Q38750852 | Human and Swine Dental Pulp Stem Cells Form a Vascularlike Network after Angiogenic Differentiation in Comparison with Endothelial Cells: A Quantitative Analysis |
| Q36393112 | Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes |
| Q36128936 | Inhibition of Breast Tumor Cell Growth by Ectopic Expression of p16/INK4A Via Combined Effects of Cell Cycle Arrest, Senescence and Apoptotic Induction, and Angiogenesis Inhibition |
| Q42105077 | Inhibition of Hypoxia-Induced Cell Motility by p16 in MDA-MB-231 Breast Cancer Cells |
| Q34919916 | Melittin suppresses HIF-1α/VEGF expression through inhibition of ERK and mTOR/p70S6K pathway in human cervical carcinoma cells |
| Q34583152 | Overexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesis |
| Q30430373 | PI3K and ERK-induced Rac1 activation mediates hypoxia-induced HIF-1α expression in MCF-7 breast cancer cells |
| Q33826204 | PRH/Hhex controls cell survival through coordinate transcriptional regulation of vascular endothelial growth factor signaling. |
| Q36201751 | Selection, Analysis and Improvement of Anti-Angiogenesis Compounds Identified by an Anti-HIF-1α Screening and Validation System |
Search more.